[Considerations, premises and promises of new therapeutic prospects in acute myocardial infarct. Preliminary trials of sodium trimethoxy-benzoyl- epsilon-aminocaproate (C3)].
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000614:Aminocaproates / Q000627:therapeutic use*; D003402:Creatine Kinase / Q000097:blood; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy*; D011188:Potassium / Q000378:metabolism*; D000637:Transaminases / Q000097:blood
D000614:Aminocaproates; D007770:L-Lactate Dehydrogenase; D000637:Transaminases; D003402:Creatine Kinase; D011188:Potassium
Considerazioni, premesse e promesse in tema di nuove prospettive terapeutiche dell'infarto miocardico acuto. Prime esperienze col trimetossi-benzoil-e-aminocaproato sodico (C3)